Clinical trials
Withdrawn Phase 2 Graft vs Host Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor College of Medicine | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Leland Metheny | 1 |
| Mesoblast International Sàrl | 1 |
| Molly Gallogly | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Tarix Pharmaceuticals | 1 |
| University of Pittsburgh | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graft vs Host Disease | 12 |
| Leukemia | 2 |
| Leukemia, Myeloid, Accelerated Phase | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Leukemia, Myeloid, Chronic-Phase | 2 |
| Myelodysplastic Syndromes | 2 |
| Anemia, Refractory | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Congenital Abnormalities | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.